Stefan Weber - Net Worth and Insider Trading
Stefan Weber Net Worth
The estimated net worth of Stefan Weber is at least $0 dollars as of 2025-04-29. Stefan Weber is the Board of Directors of Newron Pharmaceuticals SpA and owns about 0 shares of Newron Pharmaceuticals SpA (XTER:NP5) stock worth over $0. Details can be seen in Stefan Weber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stefan Weber has not made any transactions after 2024-06-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stefan Weber
Stefan Weber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stefan Weber owns 1 companies in total, including Newron Pharmaceuticals SpA (XTER:NP5) .
Click here to see the complete history of Stefan Weber’s form 4 insider trades.
Insider Ownership Summary of Stefan Weber
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XTER:NP5 | Newron Pharmaceuticals SpA | 2024-06-27 | Board of Directors |
Stefan Weber Latest Holdings Summary
Stefan Weber currently owns a total of 1 stock. Stefan Weber owns 0 shares of Newron Pharmaceuticals SpA (XTER:NP5) as of June 27, 2024, with a value of $0.
Latest Holdings of Stefan Weber
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XTER:NP5 | Newron Pharmaceuticals SpA | 2024-06-27 | 0 | 7.57 | 0 |
Holding Weightings of Stefan Weber
Stefan Weber Form 4 Trading Tracker
According to the SEC Form 4 filings, Stefan Weber has made a total of 1 transactions in Newron Pharmaceuticals SpA (XTER:NP5) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Newron Pharmaceuticals SpA is the acquisition of 2,500 shares on June 27, 2024, which cost Stefan Weber around $21,900.
Insider Trading History of Stefan Weber
- 1
Stefan Weber Trading Performance
GuruFocus tracks the stock performance after each of Stefan Weber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stefan Weber is -3.04%. GuruFocus also compares Stefan Weber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stefan Weber within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stefan Weber's insider trading performs compared to the benchmark.
Performance of Stefan Weber
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.57 |  | | | | |
| Relative Return to S&P 500(%) | -2.14 | | | | | |
Stefan Weber Ownership Network
Ownership Network List of Stefan Weber
Ownership Network Relation of Stefan Weber
Stefan Weber Owned Company Details
What does Newron Pharmaceuticals SpA do?
Who are the key executives at Newron Pharmaceuticals SpA?
Stefan Weber is the Board of Directors of Newron Pharmaceuticals SpA. Other key executives at Newron Pharmaceuticals SpA include and Supervisory Board Dr. Ulrich Köstlin .
Newron Pharmaceuticals SpA (XTER:NP5) Insider Trades Summary
Over the past 18 months, Stefan Weber made 1 insider transaction in Newron Pharmaceuticals SpA (XTER:NP5) with a net purchase of 2,500. Other recent insider transactions involving Newron Pharmaceuticals SpA (XTER:NP5) include a net purchase of 6,000 shares made by Dr. Ulrich Köstlin ,
In summary, during the past 3 months, insiders sold 0 shares of Newron Pharmaceuticals SpA (XTER:NP5) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Newron Pharmaceuticals SpA (XTER:NP5) were sold and 8,500 shares were bought by its insiders, resulting in a net purchase of 8,500 shares.
Newron Pharmaceuticals SpA (XTER:NP5)'s detailed insider trading history can be found in Insider Trading Tracker table.
Newron Pharmaceuticals SpA Insider Transactions
Stefan Weber Mailing Address
Above is the net worth, insider trading, and ownership report for Stefan Weber. Currently GuruFocus does not have mailing address information for Stefan Weber.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
